Costa Rica vs Latvia: HIV-positive TB patients on ART (antiretroviral therapy)
Costa Rica
72.0%
in 2024
Latvia
70.0%
in 2017
Costa Rica rank
123rd
Latvia rank
125th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Costa Rica
- Latvia
How they compare
Costa Rica currently reports 72.0% against 70.0% in Latvia, a difference of 2.0%.
Across all 7 years both countries report, Costa Rica has been ahead every year.
Costa Rica ranks 123rd and Latvia ranks 125th of 144 countries.
Costa Rica has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Costa Rica | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 84.0% | 55.0% | 29.0% | Costa Rica |
| 2010s | 95.7% | 60.2% | 35.5% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Costa Rica or Latvia?
- Costa Rica, at 72.0% against 70.0% in Latvia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Costa Rica and Latvia?
- 2.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Latvia?
- 7 years are reported by both, from 2005 to 2017.
- How do Costa Rica and Latvia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Costa Rica ranks 123rd and Latvia ranks 125th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.